4//SEC Filing
McDonnell Thomas P 4
Accession 0001104659-18-014880
CIK 0001467652other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:17 PM ET
Size
7.0 KB
Accession
0001104659-18-014880
Insider Transaction Report
Form 4
McDonnell Thomas P
Chief Commercial Officer
Transactions
- Award
Common Stock
2018-03-01+18,750→ 36,750 total - Award
Stock Option (Right to Buy)
2018-03-01+56,250→ 56,250 totalExercise: $8.30Exp: 2028-03-01→ Common Stock (56,250 underlying)
Footnotes (2)
- [F1]Represents shares of common stock underlying restricted stock unit grants awarded to the Reporting Person. The restricted stock units will vest in four equal, annual installments beginning on March 1, 2019.
- [F2]This stock option will vest in four equal, annual installments beginning on March 1, 2019.
Documents
Issuer
Neos Therapeutics, Inc.
CIK 0001467652
Entity typeother
Related Parties
1- filerCIK 0001647973
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 5:17 PM ET
- Size
- 7.0 KB